| HGNC Family | Endogenous ligands |
| Name | transforming growth factor, beta 2 |
| Description | This gene encodes a secreted ligand of the TGF-beta (transforming growth factor-beta) superfamily of proteins. Ligands of this family bind various TGF-beta receptors leading to recruitment and activation of SMAD family transcription factors that regulate gene expression. The encoded preproprotein is proteolytically processed to generate a latency-associated peptide (LAP) and a mature peptide, and is found in either a latent form composed of a mature peptide homodimer, a LAP homodimer, and a latent TGF-beta binding protein, or in an active form consisting solely of the mature peptide homodimer. The mature peptide may also form heterodimers with other TGF-beta family members. Disruption of the TGF-beta/SMAD pathway has been implicated in a variety of human cancers. A chromosomal translocation that includes this gene is associated with Peters' anomaly, a congenital defect of the anterior chamber of the eye. Mutations in this gene may be associated with Loeys-Dietz syndrome. This gene encodes multiple isoforms that may undergo similar proteolytic processing. [provided by RefSeq, Aug 2016] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nRecent studies have demonstrated that TGFB2 plays a pivotal role in vascular development and homeostasis. Mutations or haploinsufficiency in the TGFB2 gene are implicated in syndromes such as Loeys–Dietz, where reduced TGFB2 levels paradoxically trigger compensatory increases in TGF‐β signaling that promote aortic root aneurysms and other vasculopathies."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": ""}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nTGFB2 is also a potent inducer of cellular plasticity through its ability to trigger endothelial‐to‐mesenchymal transition (EndMT) and epithelial‐to‐mesenchymal transition (EMT). By activating a spectrum of intracellular cascades—including Smad, MAPK/ERK, PI3K, and p38 pathways—it upregulates transcription factors such as Snail, thereby promoting phenotypic conversion and enhancing cell motility. Moreover, in an acidic tumor microenvironment, autocrine TGFB2 signaling reinforces partial EMT changes and fatty acid metabolism that support invasion."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "3", "end_ref": "6"}]}, {"type": "t", "text": ""}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn malignant settings, TGFB2 drives cancer progression by modulating tumor cell invasion and metastasis. In gliomas and ovarian cancers, for instance, TGFB2 enhances the expression of proteolytic enzymes (e.g. MMP‐2) and remodels the extracellular matrix, thereby facilitating EMT and aggressive migration. In addition, TGFB2 participates in autocrine and paracrine loops regulated by transcription factors like LBX1 and CREB1, which further contribute to the acquisition of a metastatic phenotype."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "7", "end_ref": "13"}]}, {"type": "t", "text": ""}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nWithin the tumor microenvironment of colorectal and gastric cancers, TGFB2 secreted by cancer‐associated fibroblasts—as well as that induced under hypoxic conditions—converges with other pathways (such as those mediated by HIF‐1α) to activate transcription factors like GLI2. This cooperation fosters stem‐like properties, dedifferentiation, and chemoresistance, ultimately contributing to disease relapse."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "14"}]}, {"type": "t", "text": ""}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nTGFB2 exerts significant influence in the ocular system as well. Elevated levels of TGFB2 in the aqueous humor and trabecular meshwork are associated with excessive extracellular matrix deposition and compromised barrier function, processes that underlie increased intraocular pressure and the pathogenesis of primary open‐angle glaucoma."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "16", "end_ref": "18"}]}, {"type": "t", "text": ""}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn fibrotic disorders and during tissue remodeling, TGFB2 mediates extracellular matrix turnover and myofibroblast activation. It is instrumental in driving the regressing phase (catagen) of human hair follicles, modulating the expression of connective tissue growth factor in the retina, and contributing to pulmonary fibrosis in chronic inflammatory conditions."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "19", "end_ref": "23"}]}, {"type": "t", "text": ""}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nTGFB2 is intricately involved in cell differentiation and senescence. In prostatic epithelia, TGFB2 is predominantly produced and activated—often via proteolytic cleavage by enzymes such as prostate‐specific antigen—contributing to autocrine regulation and potentially to the formation of osteoblastic lesions in metastatic prostate cancer. In embryonic stem cells, TGFB2 promotes cardiomyocyte differentiation, while in mesenchymal stem cells, its downregulation is associated with reduced cell senescence."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "24", "end_ref": "27"}]}, {"type": "t", "text": ""}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nRecent findings in musculoskeletal biology have further highlighted TGFB2’s role in tendon development and repair. Transcription factors such as Mohawk directly upregulate TGFB2 by binding to its promoter, thereby enhancing tenogenic differentiation and collagen fibril growth essential for tendon repair."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "28"}]}, {"type": "t", "text": ""}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nTGFB2 also contributes to immunomodulatory functions at mucosal surfaces. Along with other TGF‐β isoforms, it is involved in the regulation of immunoglobulin A production in newborns, and exposure to TGFB isoforms in seminal plasma has been shown to modulate proinflammatory cytokine synthesis in cervical epithelial cells—processes that are critical for mucosal immunity and reproductive biology."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "29"}]}, {"type": "t", "text": ""}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn the realm of cancer epigenetics, quantitative increases in TGFB2 promoter methylation have been correlated with prostate cancer progression and a higher risk of biochemical recurrence. Such epigenetic modifications highlight TGFB2 as a promising biomarker for tumor aggressiveness and a potential target for therapeutic intervention."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "31"}]}, {"type": "t", "text": ""}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nAt the signaling level, detailed investigations have elucidated that TGFB2 functions through canonical Smad pathways and exhibits tightly regulated nucleocytoplasmic shuttling dynamics. These studies underscore how TGFB2-induced proteomic changes in ocular tissues, for instance, contribute to alterations in cell signaling and tissue integrity."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "32"}]}, {"type": "t", "text": ""}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nAdditional research has revealed TGFB2’s role in modulating the immunosuppressive environment in tumors. Glioma stem cells, for example, produce elevated levels of TGFB2, which may reinforce local immunosuppression and facilitate tumor evasion. In parallel, TGFB2 expression is regulated by microRNAs in placental tissues from preeclamptic pregnancies, further broadening its physiological significance."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "34"}]}, {"type": "t", "text": ""}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nFinally, emerging post‐transcriptional mechanisms have been identified that modulate TGFB2 expression. A highly stable G-quadruplex motif in the 5′ untranslated region of TGFB2 mRNA enhances its translation, providing novel insights into how structural RNA elements can control TGFB2 levels and offering potential new targets for therapeutic intervention."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "36"}]}, {"type": "t", "text": ""}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nA few additional studies have surveyed the broader roles of the TGF‐β family in conditions where TGFB2 may also be influential. Investigations in neonatal gut disorders have explored how incomplete macrophage differentiation predisposes to necrotizing enterocolitis, while immunohistochemical analyses in spinal cord lesions have been performed to map TGF‐β isoform distribution. These diverse contexts further underscore the broad biological and pathological relevance of TGF‐β signaling."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "30"}, {"type": "fg_f", "ref": "37"}]}, {"type": "t", "text": ""}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Mark E Lindsay, Dorien Schepers, Nikhita Ajit Bolar, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Loss-of-function mutations in TGFB2 cause a syndromic presentation of thoracic aortic aneurysm."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Genet (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/ng.2349"}], "href": "https://doi.org/10.1038/ng.2349"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22772368"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22772368"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Catherine Boileau, Dong-Chuan Guo, Nadine Hanna, et al. "}, {"type": "b", "children": [{"type": "t", "text": "TGFB2 mutations cause familial thoracic aortic aneurysms and dissections associated with mild systemic features of Marfan syndrome."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Genet (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/ng.2348"}], "href": "https://doi.org/10.1038/ng.2348"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22772371"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22772371"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Damian Medici, Scott Potenta, Raghu Kalluri "}, {"type": "b", "children": [{"type": "t", "text": "Transforming growth factor-β2 promotes Snail-mediated endothelial-mesenchymal transition through convergence of Smad-dependent and Smad-independent signalling."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem J (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1042/BJ20101500"}], "href": "https://doi.org/10.1042/BJ20101500"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21585337"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21585337"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Monika Maleszewska, Jan-Renier A J Moonen, Nicolette Huijkman, et al. "}, {"type": "b", "children": [{"type": "t", "text": "IL-1β and TGFβ2 synergistically induce endothelial to mesenchymal transition in an NFκB-dependent manner."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Immunobiology (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.imbio.2012.05.026"}], "href": "https://doi.org/10.1016/j.imbio.2012.05.026"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22739237"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22739237"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Cyril Corbet, Estelle Bastien, Joao Pedro Santiago de Jesus, et al. "}, {"type": "b", "children": [{"type": "t", "text": "TGFβ2-induced formation of lipid droplets supports acidosis-driven EMT and the metastatic spreading of cancer cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Commun (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41467-019-14262-3"}], "href": "https://doi.org/10.1038/s41467-019-14262-3"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31974393"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31974393"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Harika Sabbineni, Arti Verma, Payaningal R Somanath "}, {"type": "b", "children": [{"type": "t", "text": "Isoform-specific effects of transforming growth factor β on endothelial-to-mesenchymal transition."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Physiol (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/jcp.26801"}], "href": "https://doi.org/10.1002/jcp.26801"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29856065"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29856065"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "W Wick, M Platten, M Weller "}, {"type": "b", "children": [{"type": "t", "text": "Glioma cell invasion: regulation of metalloproteinase activity by TGF-beta."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Neurooncol (2001)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1023/a:1012209518843"}], "href": "https://doi.org/10.1023/a:1012209518843"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "11716069"}], "href": "https://pubmed.ncbi.nlm.nih.gov/11716069"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "F Arslan, A-K Bosserhoff, T Nickl-Jockschat, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The role of versican isoforms V0/V1 in glioma migration mediated by transforming growth factor-beta2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Br J Cancer (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/sj.bjc.6603766"}], "href": "https://doi.org/10.1038/sj.bjc.6603766"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17453002"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17453002"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Min Yu, Gromoslaw A Smolen, Jianmin Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A developmentally regulated inducer of EMT, LBX1, contributes to breast cancer progression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Genes Dev (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1101/gad.1809309"}], "href": "https://doi.org/10.1101/gad.1809309"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19651985"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19651985"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Hideyuki Ishihara, Hisashi Kubota, Raija L P Lindberg, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Endothelial cell barrier impairment induced by glioblastomas and transforming growth factor beta2 involves matrix metalloproteinases and tight junction proteins."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Neuropathol Exp Neurol (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1097/NEN.0b013e31816fd622"}], "href": "https://doi.org/10.1097/NEN.0b013e31816fd622"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18431253"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18431253"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Laura Rodón, Alba Gonzàlez-Juncà, María del Mar Inda, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Active CREB1 promotes a malignant TGFβ2 autocrine loop in glioblastoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Discov (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/2159-8290.CD-14-0275"}], "href": "https://doi.org/10.1158/2159-8290.CD-14-0275"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25084773"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25084773"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Hua-Yu Zhu, Wen-Dong Bai, Chao Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Knockdown of lncRNA-ATB suppresses autocrine secretion of TGF-β2 by targeting ZNF217 via miR-200c in keloid fibroblasts."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Sci Rep (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/srep24728"}], "href": "https://doi.org/10.1038/srep24728"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27090737"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27090737"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Moitri Basu, Rahul Bhattacharya, Upasana Ray, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Invasion of ovarian cancer cells is induced byPITX2-mediated activation of TGF-β and Activin-A."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cancer (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s12943-015-0433-y"}], "href": "https://doi.org/10.1186/s12943-015-0433-y"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26298390"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26298390"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Yen-An Tang, Yu-Feng Chen, Yi Bao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Hypoxic tumor microenvironment activates GLI2 via HIF-1α and TGF-β2 to promote chemoresistance in colorectal cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Proc Natl Acad Sci U S A (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1073/pnas.1801348115"}], "href": "https://doi.org/10.1073/pnas.1801348115"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29891662"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29891662"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Kecheng Lei, Xin Liang, Yuwei Gao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Lnc-ATB contributes to gastric cancer growth through a MiR-141-3p/TGFβ2 feedback loop."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Biophys Res Commun (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbrc.2017.01.094"}], "href": "https://doi.org/10.1016/j.bbrc.2017.01.094"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28115163"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28115163"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Puneet Agarwal, Aqil Mohammad Daher, Renu Agarwal "}, {"type": "b", "children": [{"type": "t", "text": "Aqueous humor TGF-β2 levels in patients with open-angle glaucoma: A meta-analysis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Vis (2015)"}]}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26019480"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26019480"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Gulab S Zode, Anirudh Sethi, Anne-Marie Brun-Zinkernagel, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Transforming growth factor-β2 increases extracellular matrix proteins in optic nerve head cells via activation of the Smad signaling pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Vis (2011)"}]}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21738403"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21738403"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Kathryn E Bollinger, John S Crabb, Xianglin Yuan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Quantitative proteomics: TGFβ₂ signaling in trabecular meshwork cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Invest Ophthalmol Vis Sci (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1167/iovs.11-8218"}], "href": "https://doi.org/10.1167/iovs.11-8218"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21917933"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21917933"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Tsutomu Soma, Yumiko Tsuji, Toshihiko Hibino "}, {"type": "b", "children": [{"type": "t", "text": "Involvement of transforming growth factor-beta2 in catagen induction during the human hair cycle."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Invest Dermatol (2002)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1046/j.1523-1747.2002.01746.x"}], "href": "https://doi.org/10.1046/j.1523-1747.2002.01746.x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12060393"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12060393"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "Takeshi Kita, Yasuaki Hata, Kumiko Kano, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Transforming growth factor-beta2 and connective tissue growth factor in proliferative vitreoretinal diseases: possible involvement of hyalocytes and therapeutic potential of Rho kinase inhibitor."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Diabetes (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.2337/db06-0581"}], "href": "https://doi.org/10.2337/db06-0581"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17192487"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17192487"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "Adrian Kruit, Jan C Grutters, Henk J T Ruven, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Transforming growth factor-beta gene polymorphisms in sarcoidosis patients with and without fibrosis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Chest (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1378/chest.129.6.1584"}], "href": "https://doi.org/10.1378/chest.129.6.1584"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16778279"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16778279"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "Eri Takahashi, Osamu Nagano, Takatsugu Ishimoto, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Tumor necrosis factor-alpha regulates transforming growth factor-beta-dependent epithelial-mesenchymal transition by promoting hyaluronan-CD44-moesin interaction."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M109.056523"}], "href": "https://doi.org/10.1074/jbc.M109.056523"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19965872"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19965872"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "E B Jude, R Blakytny, J Bulmer, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Transforming growth factor-beta 1, 2, 3 and receptor type I and II in diabetic foot ulcers."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Diabet Med (2002)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1046/j.1464-5491.2002.00692.x"}], "href": "https://doi.org/10.1046/j.1464-5491.2002.00692.x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12060054"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12060054"}]}, {"type": "r", "ref": 24, "children": [{"type": "t", "text": "Tomomi Ito, Rumi Sawada, Yoko Fujiwara, et al. "}, {"type": "b", "children": [{"type": "t", "text": "FGF-2 suppresses cellular senescence of human mesenchymal stem cells by down-regulation of TGF-beta2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Biophys Res Commun (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbrc.2007.05.067"}], "href": "https://doi.org/10.1016/j.bbrc.2007.05.067"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17532297"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17532297"}]}, {"type": "r", "ref": 25, "children": [{"type": "t", "text": "S L Dallas, S Zhao, S D Cramer, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Preferential production of latent transforming growth factor beta-2 by primary prostatic epithelial cells and its activation by prostate-specific antigen."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Physiol (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/jcp.20147"}], "href": "https://doi.org/10.1002/jcp.20147"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15389580"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15389580"}]}, {"type": "r", "ref": 26, "children": [{"type": "t", "text": "Peter J Castaldi, Michael H Cho, Raúl San José Estépar, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Genome-wide association identifies regulatory Loci associated with distinct local histogram emphysema patterns."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Respir Crit Care Med (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1164/rccm.201403-0569OC"}], "href": "https://doi.org/10.1164/rccm.201403-0569OC"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25006744"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25006744"}]}, {"type": "r", "ref": 27, "children": [{"type": "t", "text": "Dinender Kumar Singla, Baiming Sun "}, {"type": "b", "children": [{"type": "t", "text": "Transforming growth factor-beta2 enhances differentiation of cardiac myocytes from embryonic stem cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Biophys Res Commun (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbrc.2005.04.098"}], "href": "https://doi.org/10.1016/j.bbrc.2005.04.098"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15896309"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15896309"}]}, {"type": "r", "ref": 28, "children": [{"type": "t", "text": "Huanhuan Liu, Can Zhang, Shouan Zhu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Mohawk promotes the tenogenesis of mesenchymal stem cells through activation of the TGFβ signaling pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Stem Cells (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/stem.1866"}], "href": "https://doi.org/10.1002/stem.1866"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25332192"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25332192"}]}, {"type": "r", "ref": 29, "children": [{"type": "t", "text": "Jiro Ogawa, Akiko Sasahara, Taketoshi Yoshida, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Role of transforming growth factor-beta in breast milk for initiation of IgA production in newborn infants."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Early Hum Dev (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.earlhumdev.2004.01.005"}], "href": "https://doi.org/10.1016/j.earlhumdev.2004.01.005"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15113633"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15113633"}]}, {"type": "r", "ref": 30, "children": [{"type": "t", "text": "David J Sharkey, Anne M Macpherson, Kelton P Tremellen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "TGF-β mediates proinflammatory seminal fluid signaling in human cervical epithelial cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Immunol (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.4049/jimmunol.1200005"}], "href": "https://doi.org/10.4049/jimmunol.1200005"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22706080"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22706080"}]}, {"type": "r", "ref": 31, "children": [{"type": "t", "text": "Liyang Liu, Ken J Kron, Vaijayanti V Pethe, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Association of tissue promoter methylation levels of APC, TGFβ2, HOXD3 and RASSF1A with prostate cancer progression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Cancer (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/ijc.25908"}], "href": "https://doi.org/10.1002/ijc.25908"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21207416"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21207416"}]}, {"type": "r", "ref": 32, "children": [{"type": "t", "text": "Ling Yu, Wayne A Border, Yufeng Huang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "TGF-beta isoforms in renal fibrogenesis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Kidney Int (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1046/j.1523-1755.2003.00162.x"}], "href": "https://doi.org/10.1046/j.1523-1755.2003.00162.x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12911534"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12911534"}]}, {"type": "r", "ref": 33, "children": [{"type": "t", "text": "D M Bissell "}, {"type": "b", "children": [{"type": "t", "text": "Chronic liver injury, TGF-beta, and cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Exp Mol Med (2001)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/emm.2001.31"}], "href": "https://doi.org/10.1038/emm.2001.31"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "11795478"}], "href": "https://pubmed.ncbi.nlm.nih.gov/11795478"}]}, {"type": "r", "ref": 34, "children": [{"type": "t", "text": "Bo Qiu, Dongyong Zhang, Chao Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "IL-10 and TGF-β2 are overexpressed in tumor spheres cultured from human gliomas."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Biol Rep (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s11033-010-0469-4"}], "href": "https://doi.org/10.1007/s11033-010-0469-4"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21088899"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21088899"}]}, {"type": "r", "ref": 35, "children": [{"type": "t", "text": "Xinyao Zhou, Qiaoli Li, Jiawei Xu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The aberrantly expressed miR-193b-3p contributes to preeclampsia through regulating transforming growth factor-β signaling."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Sci Rep (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/srep19910"}], "href": "https://doi.org/10.1038/srep19910"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26822621"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26822621"}]}, {"type": "r", "ref": 36, "children": [{"type": "t", "text": "Prachi Agarwala, Satyaprakash Pandey, Koyeli Mapa, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The G-quadruplex augments translation in the 5' untranslated region of transforming growth factor β2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochemistry (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1021/bi301365g"}], "href": "https://doi.org/10.1021/bi301365g"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23387555"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23387555"}]}, {"type": "r", "ref": 37, "children": [{"type": "t", "text": "Akhil Maheshwari, David R Kelly, Teodora Nicola, et al. "}, {"type": "b", "children": [{"type": "t", "text": "TGF-β2 suppresses macrophage cytokine production and mucosal inflammatory responses in the developing intestine."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Gastroenterology (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1053/j.gastro.2010.09.043"}], "href": "https://doi.org/10.1053/j.gastro.2010.09.043"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20875417"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20875417"}]}]}]}
|
| Synonyms | LDS4, TGF-BETA2, G-TSF |
| Proteins | TGFB2_HUMAN |
| NCBI Gene ID | 7042 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
TGFB2 has 14,879 functional associations with biological entities spanning 9 categories (molecular profile, organism, functional term, phrase or reference, disease, phenotype or trait, chemical, structural feature, cell line, cell type or tissue, gene, protein or microRNA, sequence feature) extracted from 133 datasets.
Click the + buttons to view associations for TGFB2 from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| Achilles Cell Line Gene Essentiality Profiles | cell lines with fitness changed by TGFB2 gene knockdown relative to other cell lines from the Achilles Cell Line Gene Essentiality Profiles dataset. | |
| Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of TGFB2 gene relative to other tissues from the Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles dataset. | |
| Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles | tissues with high or low expression of TGFB2 gene relative to other tissues from the Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles dataset. | |
| Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of TGFB2 gene relative to other tissue samples from the Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles dataset. | |
| Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray | tissue samples with high or low expression of TGFB2 gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray dataset. | |
| Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq | tissue samples with high or low expression of TGFB2 gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq dataset. | |
| Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of TGFB2 gene relative to other tissues from the Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles dataset. | |
| Biocarta Pathways | pathways involving TGFB2 protein from the Biocarta Pathways dataset. | |
| BioGPS Cell Line Gene Expression Profiles | cell lines with high or low expression of TGFB2 gene relative to other cell lines from the BioGPS Cell Line Gene Expression Profiles dataset. | |
| BioGPS Human Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of TGFB2 gene relative to other cell types and tissues from the BioGPS Human Cell Type and Tissue Gene Expression Profiles dataset. | |
| BioGPS Mouse Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of TGFB2 gene relative to other cell types and tissues from the BioGPS Mouse Cell Type and Tissue Gene Expression Profiles dataset. | |
| CCLE Cell Line Gene CNV Profiles | cell lines with high or low copy number of TGFB2 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset. | |
| CCLE Cell Line Gene Expression Profiles | cell lines with high or low expression of TGFB2 gene relative to other cell lines from the CCLE Cell Line Gene Expression Profiles dataset. | |
| CCLE Cell Line Gene Mutation Profiles | cell lines with TGFB2 gene mutations from the CCLE Cell Line Gene Mutation Profiles dataset. | |
| CCLE Cell Line Proteomics | Cell lines associated with TGFB2 protein from the CCLE Cell Line Proteomics dataset. | |
| CellMarker Gene-Cell Type Associations | cell types associated with TGFB2 gene from the CellMarker Gene-Cell Type Associations dataset. | |
| ChEA Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of TGFB2 gene from the CHEA Transcription Factor Binding Site Profiles dataset. | |
| ChEA Transcription Factor Targets | transcription factors binding the promoter of TGFB2 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset. | |
| ChEA Transcription Factor Targets 2022 | transcription factors binding the promoter of TGFB2 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets 2022 dataset. | |
| ClinVar Gene-Phenotype Associations | phenotypes associated with TGFB2 gene from the curated ClinVar Gene-Phenotype Associations dataset. | |
| ClinVar Gene-Phenotype Associations 2025 | phenotypes associated with TGFB2 gene from the curated ClinVar Gene-Phenotype Associations 2025 dataset. | |
| CM4AI U2OS Cell Map Protein Localization Assemblies | assemblies containing TGFB2 protein from integrated AP-MS and IF data from the CM4AI U2OS Cell Map Protein Localization Assemblies dataset. | |
| CMAP Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of TGFB2 gene from the CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| COMPARTMENTS Curated Protein Localization Evidence Scores | cellular components containing TGFB2 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Curated Protein Localization Evidence Scores 2025 | cellular components containing TGFB2 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores 2025 dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores | cellular components co-occuring with TGFB2 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 | cellular components co-occuring with TGFB2 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset. | |
| COSMIC Cell Line Gene CNV Profiles | cell lines with high or low copy number of TGFB2 gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset. | |
| COSMIC Cell Line Gene Mutation Profiles | cell lines with TGFB2 gene mutations from the COSMIC Cell Line Gene Mutation Profiles dataset. | |
| CTD Gene-Chemical Interactions | chemicals interacting with TGFB2 gene/protein from the curated CTD Gene-Chemical Interactions dataset. | |
| CTD Gene-Disease Associations | diseases associated with TGFB2 gene/protein from the curated CTD Gene-Disease Associations dataset. | |
| dbGAP Gene-Trait Associations | traits associated with TGFB2 gene in GWAS and other genetic association datasets from the dbGAP Gene-Trait Associations dataset. | |
| DepMap CRISPR Gene Dependency | cell lines with fitness changed by TGFB2 gene knockdown relative to other cell lines from the DepMap CRISPR Gene Dependency dataset. | |
| DISEASES Curated Gene-Disease Association Evidence Scores | diseases involving TGFB2 gene from the DISEASES Curated Gene-Disease Assocation Evidence Scores dataset. | |
| DISEASES Curated Gene-Disease Association Evidence Scores 2025 | diseases involving TGFB2 gene from the DISEASES Curated Gene-Disease Association Evidence Scores 2025 dataset. | |
| DISEASES Experimental Gene-Disease Association Evidence Scores 2025 | diseases associated with TGFB2 gene in GWAS datasets from the DISEASES Experimental Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores | diseases co-occuring with TGFB2 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 | diseases co-occuring with TGFB2 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| DisGeNET Gene-Disease Associations | diseases associated with TGFB2 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset. | |
| DisGeNET Gene-Phenotype Associations | phenotypes associated with TGFB2 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Phenoptype Associations dataset. | |
| ENCODE Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at TGFB2 gene from the ENCODE Histone Modification Site Profiles dataset. | |
| ENCODE Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of TGFB2 gene from the ENCODE Transcription Factor Binding Site Profiles dataset. | |
| ENCODE Transcription Factor Targets | transcription factors binding the promoter of TGFB2 gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset. | |
| ESCAPE Omics Signatures of Genes and Proteins for Stem Cells | PubMedIDs of publications reporting gene signatures containing TGFB2 from the ESCAPE Omics Signatures of Genes and Proteins for Stem Cells dataset. | |
| GAD Gene-Disease Associations | diseases associated with TGFB2 gene in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset. | |
| GAD High Level Gene-Disease Associations | diseases associated with TGFB2 gene in GWAS and other genetic association datasets from the GAD High Level Gene-Disease Associations dataset. | |
| GDSC Cell Line Gene Expression Profiles | cell lines with high or low expression of TGFB2 gene relative to other cell lines from the GDSC Cell Line Gene Expression Profiles dataset. | |
| GeneRIF Biological Term Annotations | biological terms co-occuring with TGFB2 gene in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset. | |
| GeneSigDB Published Gene Signatures | PubMedIDs of publications reporting gene signatures containing TGFB2 from the GeneSigDB Published Gene Signatures dataset. | |
| GEO Signatures of Differentially Expressed Genes for Diseases | disease perturbations changing expression of TGFB2 gene from the GEO Signatures of Differentially Expressed Genes for Diseases dataset. | |
| GEO Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of TGFB2 gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Kinase Perturbations | kinase perturbations changing expression of TGFB2 gene from the GEO Signatures of Differentially Expressed Genes for Kinase Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of TGFB2 gene from the GEO Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations | transcription factor perturbations changing expression of TGFB2 gene from the GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Viral Infections | virus perturbations changing expression of TGFB2 gene from the GEO Signatures of Differentially Expressed Genes for Viral Infections dataset. | |
| GlyGen Glycosylated Proteins | ligands (chemical) binding TGFB2 protein from the GlyGen Glycosylated Proteins dataset. | |
| GO Biological Process Annotations 2015 | biological processes involving TGFB2 gene from the curated GO Biological Process Annotations 2015 dataset. | |
| GO Biological Process Annotations 2023 | biological processes involving TGFB2 gene from the curated GO Biological Process Annotations 2023 dataset. | |
| GO Biological Process Annotations 2025 | biological processes involving TGFB2 gene from the curated GO Biological Process Annotations2025 dataset. | |
| GO Cellular Component Annotations 2015 | cellular components containing TGFB2 protein from the curated GO Cellular Component Annotations 2015 dataset. | |
| GO Cellular Component Annotations 2023 | cellular components containing TGFB2 protein from the curated GO Cellular Component Annotations 2023 dataset. | |
| GO Cellular Component Annotations 2025 | cellular components containing TGFB2 protein from the curated GO Cellular Component Annotations 2025 dataset. | |
| GO Molecular Function Annotations 2015 | molecular functions performed by TGFB2 gene from the curated GO Molecular Function Annotations 2015 dataset. | |
| GO Molecular Function Annotations 2023 | molecular functions performed by TGFB2 gene from the curated GO Molecular Function Annotations 2023 dataset. | |
| GO Molecular Function Annotations 2025 | molecular functions performed by TGFB2 gene from the curated GO Molecular Function Annotations 2025 dataset. | |
| GTEx eQTL 2025 | SNPs regulating expression of TGFB2 gene from the GTEx eQTL 2025 dataset. | |
| GTEx Tissue Gene Expression Profiles | tissues with high or low expression of TGFB2 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset. | |
| GTEx Tissue Gene Expression Profiles 2023 | tissues with high or low expression of TGFB2 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles 2023 dataset. | |
| GTEx Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of TGFB2 gene relative to other tissue samples from the GTEx Tissue Sample Gene Expression Profiles dataset. | |
| GWAS Catalog SNP-Phenotype Associations | phenotypes associated with TGFB2 gene in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations dataset. | |
| GWAS Catalog SNP-Phenotype Associations 2025 | phenotypes associated with TGFB2 gene in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations 2025 dataset. | |
| GWASdb SNP-Disease Associations | diseases associated with TGFB2 gene in GWAS and other genetic association datasets from the GWASdb SNP-Disease Associations dataset. | |
| GWASdb SNP-Phenotype Associations | phenotypes associated with TGFB2 gene in GWAS datasets from the GWASdb SNP-Phenotype Associations dataset. | |
| Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles | cell lines with high or low expression of TGFB2 gene relative to other cell lines from the Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles dataset. | |
| HPA Cell Line Gene Expression Profiles | cell lines with high or low expression of TGFB2 gene relative to other cell lines from the HPA Cell Line Gene Expression Profiles dataset. | |
| HPA Tissue Gene Expression Profiles | tissues with high or low expression of TGFB2 gene relative to other tissues from the HPA Tissue Gene Expression Profiles dataset. | |
| HPA Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of TGFB2 gene relative to other tissue samples from the HPA Tissue Sample Gene Expression Profiles dataset. | |
| HPO Gene-Disease Associations | phenotypes associated with TGFB2 gene by mapping known disease genes to disease phenotypes from the HPO Gene-Disease Associations dataset. | |
| Hub Proteins Protein-Protein Interactions | interacting hub proteins for TGFB2 from the curated Hub Proteins Protein-Protein Interactions dataset. | |
| HuGE Navigator Gene-Phenotype Associations | phenotypes associated with TGFB2 gene by text-mining GWAS publications from the HuGE Navigator Gene-Phenotype Associations dataset. | |
| InterPro Predicted Protein Domain Annotations | protein domains predicted for TGFB2 protein from the InterPro Predicted Protein Domain Annotations dataset. | |
| JASPAR Predicted Human Transcription Factor Targets 2025 | transcription factors regulating expression of TGFB2 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Human Transcription Factor Targets dataset. | |
| JASPAR Predicted Mouse Transcription Factor Targets 2025 | transcription factors regulating expression of TGFB2 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Mouse Transcription Factor Targets 2025 dataset. | |
| JASPAR Predicted Transcription Factor Targets | transcription factors regulating expression of TGFB2 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset. | |
| KEGG Pathways | pathways involving TGFB2 protein from the KEGG Pathways dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles | cell lines with high or low copy number of TGFB2 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles | cell lines with high or low expression of TGFB2 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles | cell lines with TGFB2 gene mutations from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles dataset. | |
| KnockTF Gene Expression Profiles with Transcription Factor Perturbations | transcription factor perturbations changing expression of TGFB2 gene from the KnockTF Gene Expression Profiles with Transcription Factor Perturbations dataset. | |
| LINCS L1000 CMAP Chemical Perturbation Consensus Signatures | small molecule perturbations changing expression of TGFB2 gene from the LINCS L1000 CMAP Chemical Perturbations Consensus Signatures dataset. | |
| LINCS L1000 CMAP CRISPR Knockout Consensus Signatures | gene perturbations changing expression of TGFB2 gene from the LINCS L1000 CMAP CRISPR Knockout Consensus Signatures dataset. | |
| LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of TGFB2 gene from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| LOCATE Curated Protein Localization Annotations | cellular components containing TGFB2 protein in low- or high-throughput protein localization assays from the LOCATE Curated Protein Localization Annotations dataset. | |
| LOCATE Predicted Protein Localization Annotations | cellular components predicted to contain TGFB2 protein from the LOCATE Predicted Protein Localization Annotations dataset. | |
| MGI Mouse Phenotype Associations 2023 | phenotypes of transgenic mice caused by TGFB2 gene mutations from the MGI Mouse Phenotype Associations 2023 dataset. | |
| MiRTarBase microRNA Targets | microRNAs targeting TGFB2 gene in low- or high-throughput microRNA targeting studies from the MiRTarBase microRNA Targets dataset. | |
| MotifMap Predicted Transcription Factor Targets | transcription factors regulating expression of TGFB2 gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset. | |
| MoTrPAC Rat Endurance Exercise Training | tissue samples with high or low expression of TGFB2 gene relative to other tissue samples from the MoTrPAC Rat Endurance Exercise Training dataset. | |
| MPO Gene-Phenotype Associations | phenotypes of transgenic mice caused by TGFB2 gene mutations from the MPO Gene-Phenotype Associations dataset. | |
| MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations | gene perturbations changing expression of TGFB2 gene from the MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations dataset. | |
| NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles | drug perturbations changing expression of TGFB2 gene from the NIBR DRUG-seq U2OS MoA Box dataset. | |
| NURSA Protein Complexes | protein complexs containing TGFB2 protein recovered by IP-MS from the NURSA Protein Complexes dataset. | |
| OMIM Gene-Disease Associations | phenotypes associated with TGFB2 gene from the curated OMIM Gene-Disease Associations dataset. | |
| PANTHER Pathways | pathways involving TGFB2 protein from the PANTHER Pathways dataset. | |
| Pathway Commons Protein-Protein Interactions | interacting proteins for TGFB2 from the Pathway Commons Protein-Protein Interactions dataset. | |
| PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of TGFB2 gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| PerturbAtlas Signatures of Differentially Expressed Genes for Mouse Gene Perturbations | gene perturbations changing expression of TGFB2 gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| PFOCR Pathway Figure Associations 2023 | pathways involving TGFB2 protein from the PFOCR Pathway Figure Associations 2023 dataset. | |
| PFOCR Pathway Figure Associations 2024 | pathways involving TGFB2 protein from the Wikipathways PFOCR 2024 dataset. | |
| PID Pathways | pathways involving TGFB2 protein from the PID Pathways dataset. | |
| Reactome Pathways 2014 | pathways involving TGFB2 protein from the Reactome Pathways dataset. | |
| Reactome Pathways 2024 | pathways involving TGFB2 protein from the Reactome Pathways 2024 dataset. | |
| Replogle et al., Cell, 2022 RPE1 Essential Perturb-seq Gene Perturbation Signatures | gene perturbations changing expression of TGFB2 gene from the Replogle et al., Cell, 2022 RPE1 Essential Perturb-seq Gene Perturbation Signatures dataset. | |
| Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles | cell types and tissues with high or low DNA methylation of TGFB2 gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles dataset. | |
| Roadmap Epigenomics Cell and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of TGFB2 gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue Gene Expression Profiles dataset. | |
| Roadmap Epigenomics Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at TGFB2 gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset. | |
| RummaGEO Drug Perturbation Signatures | drug perturbations changing expression of TGFB2 gene from the RummaGEO Drug Perturbation Signatures dataset. | |
| RummaGEO Gene Perturbation Signatures | gene perturbations changing expression of TGFB2 gene from the RummaGEO Gene Perturbation Signatures dataset. | |
| Sanger Dependency Map Cancer Cell Line Proteomics | cell lines associated with TGFB2 protein from the Sanger Dependency Map Cancer Cell Line Proteomics dataset. | |
| Sci-Plex Drug Perturbation Signatures | drug perturbations changing expression of TGFB2 gene from the Sci-Plex Drug Perturbation Signatures dataset. | |
| Tabula Sapiens Gene-Cell Associations | cell types with high or low expression of TGFB2 gene relative to other cell types from the Tabula Sapiens Gene-Cell Associations dataset. | |
| Tahoe Therapeutics Tahoe 100M Perturbation Atlas | drug perturbations changing expression of TGFB2 gene from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset. | |
| TargetScan Predicted Conserved microRNA Targets | microRNAs regulating expression of TGFB2 gene predicted using conserved miRNA seed sequences from the TargetScan Predicted Conserved microRNA Targets dataset. | |
| TargetScan Predicted Nonconserved microRNA Targets | microRNAs regulating expression of TGFB2 gene predicted using nonconserved miRNA seed sequences from the TargetScan Predicted Nonconserved microRNA Targets dataset. | |
| TCGA Signatures of Differentially Expressed Genes for Tumors | tissue samples with high or low expression of TGFB2 gene relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores | tissues with high expression of TGFB2 protein from the TISSUES Curated Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of TGFB2 protein from the TISSUES Curated Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Experimental Tissue Protein Expression Evidence Scores | tissues with high expression of TGFB2 protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of TGFB2 protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores | tissues co-occuring with TGFB2 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 | tissues co-occuring with TGFB2 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset. | |
| WikiPathways Pathways 2014 | pathways involving TGFB2 protein from the Wikipathways Pathways 2014 dataset. | |
| WikiPathways Pathways 2024 | pathways involving TGFB2 protein from the WikiPathways Pathways 2024 dataset. | |